Cetyldimethylethylammonium Bromide
CAS No. 124-03-8
Cetyldimethylethylammonium Bromide( —— )
Catalog No. M28881 CAS No. 124-03-8
Cetyldimethylethylammonium Bromide can be used to induce extracellular secretion of beta-galactosidase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | In Stock |
|
| 10MG | 264 | In Stock |
|
| 25MG | 474 | In Stock |
|
| 50MG | 686 | In Stock |
|
| 100MG | 963 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1917 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCetyldimethylethylammonium Bromide
-
NoteResearch use only, not for human use.
-
Brief DescriptionCetyldimethylethylammonium Bromide can be used to induce extracellular secretion of beta-galactosidase.
-
DescriptionCetyldimethylethylammonium Bromide can be used to induce extracellular secretion of beta-galactosidase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorinflammation|Antioxidant
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number124-03-8
-
Formula Weight378.483
-
Molecular FormulaC20H44BrN
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[Br-].CCCCCCCCCCCCCCCC[N+](C)(C)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Comparative antioxidant and antiplasmodial activities of 11-O-galloylbergenin and bergenin isolated from Bergenia ligulata. Trop Biomed. 2014 Mar;31(1):143-8.
molnova catalog
related products
-
YPC-22026
YPC-22026 has potential anticancer activity, inducing tumor regression in a mouse xenograft model while inhibiting ZNF143-regulated genes.
-
Neoglycyrol
Neoglycyrol shows some cardioprotective effects .
-
Brr2 Inhibitor C9
Brr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
Cart
sales@molnova.com